2 completed, 2 withdrawn, 1 recruiting, 1 unknown. 4 Phase 4, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Withdrawn 2, Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Hydrochlorothiazide 25 mg: new trials by email Literature Review of Hydrochlorothiazide 25 mg trials Research Report on Hydrochlorothiazide 25 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life Hydrochlorothiazide 25 mg, Placebo - ADPKD | Phase 3 | Recruiting | University Medical Center Groningen | 300 | 2024-07-31 | 2026-08-25 |
| Dapagliflozin Effect on Erythropoiesis and Physical Fitness Dapagliflozin (Forxiga®), Hydrochlorothiazide 25 mg, Placebo matching Dapagliflozin - Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Withdrawn | University Hospital Tuebingen | 2021-09-01 | 2021-12-15 | |
| Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension SHR0532, SHR placebo, Hydrochlorothiazide 25 mg - Hypertension | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 36 | 2019-07-31 | 2021-10-18 |
| Empagliflozin and Sympathetic Nerve Traffic Empagliflozin, Hydrochlorothiazide 25 mg - Type 2 Diabetes Mellitus | Phase 4 | Completed | Profil Institut für Stoffwechselforschung GmbH | 75 | 2017-12-08 | 2020-07-14 |
| Chlorthalidone and HCTZ Impacts on Platelet Activation Chlorthalidone 12.5 mg, Hydrochlorothiazide 25 mg, Aspirin 81 mg - Hypertension | Phase 4 | Unknown | Creighton University | 30 | 2014-03-01 | 2015-12-14 |
| Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function Chlorthalidone 12.5 mg, Hydrochlorothiazide 25 mg, Placebo - Hypertension | Phase 4 | Withdrawn | Creighton University | 2013-03-01 | 2015-03-25 |
Hypertension (3) · Diabetes Mellitus, Type 2 (2) · Polycystic Kidney, Autosomal Dominant (1) · Polyuria (1)
Creighton University (2) · Jiangsu HengRui Medicine Co., Ltd. (1) · Profil Institut für Stoffwechselforschung GmbH (1) · University Hospital Tuebingen (1) · University Medical Center Groningen (1)
Germany (3) · United States (2) · Austria (1) · Belgium (1) · China (1) · France (1) · Netherlands (1) · Spain (1) · Switzerland (1)
Ahmed Aboeata, MBBCh (1) · Khalid Bashir, MD (1) · Tim Heise, MD (1)